Cosette Pharmaceuticals, Inc.

Pharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 1 drug with upcoming expirations

Activity

Key Events

Jul 11, 2025TrialSingle Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk

Jun 21, 2019FDAVyleesi (autoinjector) — VYLEESI (AUTOINJECTOR)

Apr 3, 2019FDAWelchol — WELCHOL

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

2 patent groups across drugs · Source: FDA Orange Book

DrugExpires

Vyleesi (autoinjector)3 patentsNov 5, 2033 Vyleesi (autoinjector)Apr 29, 2041

Regulatory

Regulatory Timeline

20003 events

FDAMay 26

Welchol — WELCHOL

Application NDA021176 (NDA)

FDAMay 26

Welchol — WELCHOL

Application NDA021141 (NDA)

FDAJan 11

Evoxac — EVOXAC

Application NDA020989 (NDA)

20021 event

FDAApr 25

Benicar — BENICAR

Application NDA021286 (NDA)

20092 events

FDAOct 2

Welchol — WELCHOL

Application NDA022362 (NDA)

FDAJul 10

Effient — EFFIENT

Application NDA022307 (NDA)

20192 events

FDAJun 21

Vyleesi (autoinjector) — VYLEESI (AUTOINJECTOR)

Application NDA210557 (NDA)

FDAApr 3

Welchol — WELCHOL

Application NDA210895 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)